Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20+
SponsorNational Taiwan University Hospital
About this trial
The purpose of the registry is to collect data on the performance of the focused ultrasound (FUS) technology and health outcomes. A wide variety of approaches exist for using FUS on pancreatic cancer patients, and the primary goal is to capture this broad spectrum of approaches and their impact on patients overall health. This information will help provide a better understanding of current care, and may possibly direct further, more specific investigations that will follow this registry.
Eligibility criteria
Qualifiers
20 years and older
Provision of signed and dated informed consent form
Stated willingness to comply with all registry procedures and availability for the duration of the registry
Histology proven pancreatic carcinoma in any area of pancreas
Disqualifiers
Any disease, condition or surgery which would result in a contraindication to undergoing FUS therapy.
Clinical trials of pancreatic cancer not of focused ultrasound or related activities
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov